Drug Information and Pharmacotherapy

DI-057

UTILITY OF A NEW TOOL TO GUIDE DEPRESCRIBING IN CHRONIC PATIENTS: A CHART REVIEW

DI-056

LINEZOLID INDUCED THROMBOCYTOPENIA IN A PATIENT WITH RENAL INSUFFICIENCY: A CASE REPORT AND A RETROSPECTIVE CASE STUDY

DI-055

EVALUATION OF TOCILIZUMAB RESPONSE IN RHEUMATOID ARTHRITIS. COMPARISION OF THE RESULTS WITH THE CLINICAL TRIAL

DI-054

SAFETY RESULTS OF DIRECT ACTING ANTIVIRALS FOR THE TREATMENT OF HEPATITIS C VIRUS INFECTION

DI-053

ADHERENCE, QUALITY OF LIFE AND PATIENT SATISFACTION WITH DALFAMPRIDINE IN CLINICAL PRACTICE

DI-051

TOLVAPTAN OFF-LABEL USE IN HYPONATRAEMIA DUE TO HEART FAILURE. A CASE SERIES

DI-050

COMPARATIVE STUDY OF QUALITY INDICATORS OF PRESCRIPTION AT HOSPITALS IN A PUBLIC HEALTHCARE SYSTEM

DI-049

DURATION OF NATALIZUMAB MAINTENANCE IN PATIENTS WITH MULTIPLE SCLEROSIS

DI-048

PHARMACEUTICAL CARE PROGRAMME IN FERTILITY TREATMENTS: ANALYSIS OF PATIENT SATISFACTION LEVELS

DI-047

HIGH RISK MEDICATION: ANALYSIS OF KCL ADMINISTRATION

DI-046

DIFFERENCES IN TREATMENT DURATION IN PANCREATIC CANCER PATIENTS TREATED WITH CHEMOTHERAPY FROM 2005 TO 2014

DI-044

INAPPROPIATE USE OF OSELTAMIVIR IN HOSPITALISED PATIENTS

DI-043

EVALUATION OF THERAPEUTIC ADHERENCE AND RELATED FACTORS IN PATIENTS AFFECTED BY MULTIPLE SCLEROSIS

DI-042

MANAGEMENT OF LIPOSOMAL ANTHRACYCLINE EXTRAVASATIONS: USE OF DESRAZOXANE

DI-041

DESIGN OF A METHODOLOGY FOR CULTURAL TRANSLATION AND ADAPTATION OF THE ADHERENCE TO REFILLS AND MEDICATIONS SCALE (ARMS)

Pages